SunTrust Initiates Coverage on Several Drug Manufacturers & Suppliers
More News related to ACL
- Novartis (NVS) has no plans to buy out Alcon (ACL) minority shares - Bloomberg
- Alcon (ACL) Jumps On Takeover Chatter
- Anthony Clark - Financial Results Highlights for the Three Months and Six Months Ended September 30, 2009
- NovaBay Pharmaceuticals Reports Third Quarter Financials and Provides Update on Pipeline of Anti-Infective Compounds
- Alcon Posts 5.9 Percent Sales Growth for Third Quarter
More News related to AGN
- Spectrum Pharma (SPPI) and Handok Pharma Announce Plans for Apaziquone Development in South Korea
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Spectrum Pharma (SPPI) To Collaborate with Nippon Kayaku to Develop and Commercialize Apaziquone in Asia
- The Lowe Law Firm Files Suit over Alleged Botox Overdose
- Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
More News related to CEPH
- Jefferies & Co Upgrades Cephalon (CEPH) to Buy
- Cephalon (CEPH) options active on flat volatility; shares sell off 7% on clinical trial
- Unusual 11 Mid-Day Movers 11/23: ABIO, SEED, FNET, CDTI Higher; NYNY, GGR, TTIL, PEET Lower
- RBC Downgrades Cephalon (CEPH) Following Cinquil Trial Results; Sees 'Little Momentum' Behind the Stock
- Baird Maintains a 'Neutral' Rating on Cephalon (CEPH), Reslizumab Mixed Results in EE Sets Back Potential for Upside
More News related to New Coverage
- Notable ETF Movers 12/2: GDX, TUR Up; UNG, USO, THD Down
- Notable Analyst Rating Changes 12/2: AMR/UAUA, RFMD, STI, SAY, KBH, BBT Upgraded; STZ, MTL, BWP, POM Downgraded
- Notable Mergers and Acquisitions of the Day 12/2: DDRX/GMCR/PEET, AGU/CF, ZINC
- Morning Movers 12/02: ABCW, SNTS, BIOF, DYAX, SYMX Higher; HEB, PEIX Lower
- After-Hours Movers 12/01: SNTS, ABCW, RAME, GAME Higher; HEB, SWS, RGNC, LTXC Lower
SunTrust initiates coverage on Alcon (NYSE: ACL), Allergan (NYSE: AGN), Ista Pharmaceuticals (Nasdaq: ISTA), Sepracor (Nasdaq: SEPR), & Shire (Nasdaq: SHPGY) with a Buy.\
SunTrust's price target on ACL is $155, AGN $58, ISTA $5, SEPR $24 & SHPGY is $53.
SunTrust initiates coverage on Cephalon (Nasdaq: CEPH) & Forest Labs (NYSE: FRX) with a Neutral rating.
Related Categories
New CoverageStocks Mentioned
+9.41
-0.51Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
